ABSTRAKSI Pemilihan pemilihan detergen oleh konsumen dalam ...
Pemilihan Regimen Antibiotika.pdf
Transcript of Pemilihan Regimen Antibiotika.pdf
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
1/9
10/7/20
Pemilihan Regimen Antibiotika
Systematic Approach for Selection of
Antimicrobials
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
2/9
10/7/20
Mengetahui adanya infeksi
1. Demam Suhu tubuh di atas rentang normal (36.7-37oC)
Manifestasi dari penyakit lain.
Drug-induced fever.
2. Tanda dan gejala WBC rentang normal 4000-10000/mm3 , pada kondisi
infeksi jumlah leukosit perifer bisa mencapai 30000-4000/mm.
infeksi bakteri peningktan jumlah granulosit, often withimmature forms (band neutrophils) seen in peripheral bloodsmears.
Leukositosis respon normal dari hostterhadap infeksi.
3. Tanda-tanda Lokal
Nyeri dan Inflamasi swelling, erythema,
tenderness, and purulent drainage
infection is superficial or in a bone or joint
deep-seated infectionsmeningitis,
pneumonia, endocarditis, and urinary tractinfection examining tissues or fluids.
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
3/9
10/7/20
Identifikasi Patogen
Mengkultur bagian tubuh yg terinfeksi
sebelum diberikan terapi antimikroba
mengetahui mikroba yg menjadi penyebab.
Jika setelah tx dikultur false negative
Dalam pengambilan kultur, hati2 terhadap
kontaminasi.
Pemilihan terapi yang tepat
Select rational antimicrobial therapy for a given clinicalsituation, a variety of factors must be considered.
These include the severity and acuity of the disease, hostfactors, factors related to the drugs used, and thenecessity for using multiple agents
There are generally accepted drugs of choice for thetreatment of most pathogens
When selecting antimicrobial regimens, local susceptibilitydata should be considered whenever possible rather thaninformation published by other institutions or nationalcompilations
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
4/9
10/7/20
Host Factor
When evaluating a patient for initial or empiric therapy, thefollowing factors should be considered:
Allergy or history of adverse drug reactions
Age of patient
Pregnancy
Metabolic abnormalities
Renal and hepatic function
Concomitant drug therapy
Patients with diminished renal and/or hepatic function willaccumulate certain drugs unless dosage is adjusted. Anyconcomitant therapy the patient is receiving may influencethe selection of drug therapy, the dose, and monitoring
Drug Factor Integration of both pharmacokinetic and
pharmacodynamic properties of an agent is importantwhen choosing antimicrobial therapy to ensure efficacy andprevent resistance
Antibiotics may demonstrate concentration-dependent(aminoglycosides and fluoroquinolones) or time-dependent (-lactams) bactericidal effects.
The importance of tissue penetration varies with the site of
infection
The most important pharmacodynamic relationship forantimicrobials that display time-dependent bactericidaleffects is the duration that drug concentrations exceed theMIC.
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
5/9
10/7/20
COMBINATION ANTIMICROBIAL
THERAPY
Generally used to:
broaden the spectrum of coverage for empiric therapy
achieve synergistic activity against the infecting
organism
prevent the emergence of resistance
Increasing the coverage of antimicrobial therapy
is generally necessary in mixed infections wheremultiple organisms are likely to be present
Synergism
Traditionally, combinations of aminoglycosides and -lactams have been used since these drugs togethergenerally act synergistically against a wide variety ofbacteria.
Synergistic combinations may produce better results ininfections caused by Pseudomonas aeruginosa
The use of combinations to prevent the emergence of
resistance is widely applied but not often realized. Theonly circumstance where this has been clearly effectiveis in the treatment of tuberculosis
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
6/9
10/7/20
Disadvantages of Combination
Therapy
increased cost
greater risk of drug toxicity
superinfection with even more resistant
bacteria
MONITORING THERAPEUTIC
RESPONSE
Culture and sensitivity reports from specimenscollected must be reviewed
Use of agents with the narrowest spectrum of activityagainst identified pathogens is recommended
Patient monitoring should include a variety ofparameters, including white blood cell count,
temperature, signs and symptoms of infection,appetite, radiologic studies as appropriate, anddetermination of antimicrobial concentrations inbody fluids
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
7/9
10/7/20
As the patient improves the route of antibioticadministration should be reevaluated. Switch tooral therapy is an accepted practice for manyinfections. Criteria favoring switch to oral therapyinclude:
Overall clinical improvement
Lack of fever for 8 to 24 hours
Decreased WBC
A functioning GI tract
FAILURE OF ANTIMICROBIAL THERAPY
disease is not infectious or nonbacterial in
origin
undetected pathogen
Laboratory error in identification and/or
susceptibility testing errors are rare.
drug selection the host/pathogen.
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
8/9
10/7/20
Failures Caused by Drug Selection
Inappropriate selection of drug, dosage, or
route of administration
Malabsorption of a drug product because of
GI disease or a drug interaction
Accelerated drug elimination
poor penetration into the site of infection
Failures Caused by Host Factors
Patients who are immunosuppressed (e.g.,granulocytopenia from chemotherapy, acquiredimmune deficiency syndrome) may respond poorly totherapy because their own defenses are inadequate toeradicate the infection despite seemingly adequatedrug regimens
Other host factors are related to the necessity for
surgical drainage of abscesses or removal of foreignbodies and/or necrotic tissue. If these situations arenot corrected, they result in persistent infection and,occasionally, bacteremia, despite adequateantimicrobial therapy..
-
8/11/2019 Pemilihan Regimen Antibiotika.pdf
9/9
10/7/20
Failures Caused by Microorganisms
Development of drug resistance during therapy.
Primary resistance refers to the intrinsic resistance ofthe pathogens producing the infection. However,acquisition of resistance during treatment has becomea major problem as well.
Resistance overuse of antimicrobials in thecommunity, as well as in hospitals, and the increasingprevalence of immunosuppressed patients receivinglong-term suppressive antimicrobials for theprevention of infections